| scholarly article | Q13442814 |
| P50 | author | Mingyue Zheng | Q43370955 |
| P2093 | author name string | Dong-Mei Zhao | |
| Mao-Sheng Cheng | |||
| Bing Xiong | |||
| Jing Ai | |||
| Xia Peng | |||
| Jing-Kang Shen | |||
| Mei-Yu Geng | |||
| Dan-Qi Chen | |||
| Yin-Chun Ji | |||
| Yu-Chi Ma | |||
| Tong-Chao Liu | |||
| P2860 | cites work | Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 |
| The protein kinase complement of the human genome | Q24324497 | ||
| Discovery of 4-azaindoles as novel inhibitors of c-Met kinase | Q27654792 | ||
| Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK) | Q27671432 | ||
| Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. | Q27853074 | ||
| Met, metastasis, motility and more | Q28235183 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| Invasive growth: a MET-driven genetic programme for cancer and stem cells | Q28253680 | ||
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family | Q28285975 | ||
| Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations | Q33551889 | ||
| alpha2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells | Q33552709 | ||
| Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy | Q33652455 | ||
| Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells | Q33823715 | ||
| Invasive growth: from development to metastasis | Q34584035 | ||
| Drug development of MET inhibitors: targeting oncogene addiction and expedience | Q34782774 | ||
| Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis | Q37065772 | ||
| Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo | Q37729958 | ||
| MET signalling: principles and functions in development, organ regeneration and cancer | Q37811895 | ||
| Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress | Q38169807 | ||
| ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. | Q39702478 | ||
| c-Met is essential for wound healing in the skin | Q39735911 | ||
| Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains | Q40178199 | ||
| Scatter factor is a fibroblast-derived modulator of epithelial cell mobility | Q42807925 | ||
| Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Q45345810 | ||
| Design and optimization of a series of 1-sulfonylpyrazolo[4,3-b]pyridines as selective c-Met inhibitors. | Q53621099 | ||
| Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction | Q58164795 | ||
| Series Introduction: Invasive growth: from development to metastasis | Q58165151 | ||
| c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype | Q77583076 | ||
| Clinical significance of c-met oncogene alterations in human colorectal cancer | Q77796048 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 698-707 | |
| P577 | publication date | 2016-04-04 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors | |
| P478 | volume | 37 |
| Q57471713 | Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling |
| Q41344857 | Clinicopathological and prognostic significance of c-Met overexpression in breast cancer |
| Q58129391 | [Design and synthesis of imidazo-fused heterocycles derivatives and their anti-tumor activity against breast cancer in mice] |
Search more.